Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Sampre Nutritions
Join Channel
Consolidated Standalone

Sampre Nutritions

₹58 -2 | 3.3%

Market Cap ₹0 Cr.

Stock P/E -569.2

P/B 1.8

Current Price ₹58

Book Value ₹ 32.4

Face Value 10

52W High ₹99.3

Dividend Yield 0%

52W Low ₹ 46.6

Edit Ratio

Sampre Nutritions Research see more...

Overview Inc. Year: 1991Industry: Consumer Food

Sampre Nutritions Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Sampre Nutritions Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 3 6 7 7 8 8 9 7 6 7
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 6 7 7 8 8 9 7 6 7
Total Expenditure 3 4 6 7 7 7 8 7 5 6
Operating Profit -0 2 1 0 1 1 1 -0 1 1
Interest 0 1 0 0 0 1 0 0 0 0
Depreciation 0 0 0 0 0 0 1 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 1 0 -0 0 0 0 -1 0 0
Provision for Tax 0 0 0 -0 0 -0 0 0 0 0
Profit After Tax -1 1 0 -0 0 0 0 -1 0 0
Adjustments 0 -0 0 -0 0 0 -0 -0 -0 0
Profit After Adjustments -1 1 0 -0 0 0 0 -1 0 0
Adjusted Earnings Per Share -2.1 2.7 0.5 -0.3 0.7 0.4 0.2 -1.2 0.5 0.3

Sampre Nutritions Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 11 15 10 45 34 33 29 25 18 23 37 29
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 11 15 10 45 34 33 29 25 18 23 37 29
Total Expenditure 9 14 8 42 31 30 25 21 15 20 33 26
Operating Profit 2 2 2 3 3 3 4 4 3 4 4 3
Interest 0 0 0 1 1 1 2 2 2 2 2 0
Depreciation 1 1 1 1 1 1 1 1 2 2 2 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 1 1 0 0 0 0 0 0 -1
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 1 0 0 0 0 0 0 0 -1
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 1 0 0 0 0 0 0 0 -1
Adjusted Earnings Per Share 0.4 0.7 0.3 1.8 0.9 0.5 0.5 0.7 0.2 0.6 0.5 -0.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 61% 14% 2% 13%
Operating Profit CAGR 0% 0% 6% 7%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -22% 49% 27% 18%
ROE Average 2% 2% 2% 3%
ROCE Average 7% 6% 7% 7%

Sampre Nutritions Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 8 8 9 9 10 10 10 11 11 11 21
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 2 4 7 9 11 11 12 13 11
Other Non-Current Liabilities 1 1 0 0 0 1 0 0 1 1 0
Total Current Liabilities 4 5 6 10 9 7 16 15 15 13 11
Total Liabilities 13 15 17 24 26 27 38 37 38 38 44
Fixed Assets 9 10 10 9 9 13 15 19 18 22 21
Other Non-Current Assets 0 0 0 4 7 4 10 6 6 1 7
Total Current Assets 4 4 7 11 10 10 13 13 14 14 16
Total Assets 13 15 17 24 26 27 38 37 38 38 44

Sampre Nutritions Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 1 0 0
Cash Flow from Operating Activities 4 0 -0 1 -1 1 6 3 -0 2 1
Cash Flow from Investing Activities -1 -3 -1 -4 -3 -2 -10 -1 -1 -1 -4
Cash Flow from Financing Activities -4 3 1 3 4 0 5 -1 0 -2 3
Net Cash Inflow / Outflow -0 -0 -0 0 0 -0 0 1 -1 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 1 0 0 0

Sampre Nutritions Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.35 0.7 0.27 1.78 0.94 0.5 0.48 0.7 0.16 0.64 0.51
CEPS(Rs) 2.54 3.16 2.69 4.18 3.61 3.58 3.38 3.79 3.91 4.03 3.16
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 16.49 17.53 17.8 19.6 20.39 20.89 21.45 22.21 22.37 23.01 27.39
Core EBITDA Margin(%) 14.02 11.88 16.94 6.1 8.86 9.31 13.03 15.7 18.8 15.11 10.93
EBIT Margin(%) 4.48 4.75 6.91 3.68 5.27 5.09 8.28 10.42 9.06 9.25 6.21
Pre Tax Margin(%) 1.94 2.89 2.09 2.24 1.97 1.48 0.84 1.83 0.6 1.61 1.12
PAT Margin (%) 1.57 2.21 1.28 1.9 1.35 0.74 0.81 1.35 0.41 1.33 0.94
Cash Profit Margin (%) 11.3 9.94 12.87 4.47 5.18 5.29 5.67 7.36 10.33 8.4 5.84
ROA(%) 1.28 2.49 0.83 4.25 1.81 0.91 0.71 0.89 0.2 0.81 0.85
ROE(%) 2.3 4.14 1.52 9.53 4.69 2.43 2.27 3.19 0.7 2.81 2.32
ROCE(%) 4.79 7.57 6.09 11.14 8.79 7.06 8.71 8.45 5.26 6.65 6.56
Receivable days 85.07 64.53 127.62 39.44 59.21 52.37 60.54 62.9 98.09 96.25 66.14
Inventory Days 5.2 3.64 25.82 15.75 33.05 47.61 69.08 95.21 143.43 113.53 69.51
Payable days 272.94 123.88 226.46 30.83 51.8 34.24 76.96 242.37 476.11 239.59 91.86
PER(x) 28.48 13.62 31.34 30.9 43.69 98.61 58.49 24.41 93.43 50.97 180.68
Price/Book(x) 0.61 0.55 0.47 2.81 2.01 2.37 1.31 0.77 0.65 1.41 3.33
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.51 0.43 0.78 0.76 0.97 1.16 1.16 1.11 1.55 1.59 2.14
EV/Core EBITDA(x) 3.62 3.42 4.24 12.14 10.66 11.99 8.81 6.74 8.15 9.76 19.22
Net Sales Growth(%) 32.52 41.69 -34.15 346.86 -25.52 -2.78 -12.15 -13.34 -26.64 26.83 60.46
EBIT Growth(%) -65.95 50.34 -4.26 138.26 6.58 -6.12 42.89 9 -36.2 29.46 7.82
PAT Growth(%) -3.81 100.33 -61.9 564.78 -47.4 -46.39 -4.55 45.23 -77.48 307.14 12.74
EPS Growth(%) -3.82 100.35 -61.9 564.78 -47.4 -46.39 -4.55 45.23 -77.49 307.27 -20.91
Debt/Equity(x) 0.11 0.23 0.46 0.84 1.33 1.4 1.94 1.88 1.97 1.91 0.89
Current Ratio(x) 1.05 0.85 1.16 1.08 1.1 1.4 0.81 0.84 0.96 1.08 1.46
Quick Ratio(x) 0.98 0.85 0.92 0.84 0.71 0.74 0.44 0.38 0.47 0.55 0.83
Interest Cover(x) 1.76 2.55 1.43 2.56 1.6 1.41 1.11 1.21 1.07 1.21 1.22
Total Debt/Mcap(x) 0.18 0.42 0.97 0.3 0.66 0.59 1.48 2.46 3.01 1.35 0.27

Sampre Nutritions Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 52.78 52.78 52.78 52.78 37.03 37.03 37.03 37.03 37.03 34.99
FII 0 0 0 1.04 0.73 0.73 0.73 0.73 0.73 0.41
DII 0 0 0 0 0 0 0 0 0 0
Public 47.22 47.22 47.22 46.18 62.24 62.24 62.24 62.24 62.24 64.59
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 239.59 to 91.86days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 34.99%.
  • Company has a low return on equity of 2% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sampre Nutritions News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!